Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Yan-Jun Hu
Low Expression of Stathmin in Tumor Predicts High Response to Neoadjuvant Chemotherapy With Docetaxel-Containing Regimens in Locally Advanced Breast Cancer
Genetic Testing and Molecular Biomarkers
Medicine
Genetics
Related publications
MRI-Based Radiomics Predicts Tumor Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer
Frontiers in Oncology
Cancer Research
Oncology
99mTc-Sestamibi Scintigraphy Used to Evaluate Tumor Response to Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer: A Quantitative Analysis
Oncology Letters
Cancer Research
Oncology
Prolonged Neoadjuvant Chemotherapy With GM‐CSF in Locally Advanced Breast Cancer
Oncologist
Cancer Research
Medicine
Oncology
Neoadjuvant 5-Fluorouracil, Epirubicin and Cyclophosphamide Chemotherapy Followed by Docetaxel in Refractory Patients With Locally Advanced Breast Cancer
Oncology Reports
Medicine
Cancer Research
Oncology
Sirtuin1 Expression Predicts the Efficacy of Neoadjuvant Chemotherapy for Locally Advanced Uterine Cervical Cancer
Molecular and Clinical Oncology
Cancer Research
Oncology
The Influence of Obesity on Results of AT (Doxorubicin Plus Docetaxel) Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer Patients
Polski Przeglad Chirurgiczny
Medicine
Surgery
Complete Pathological Response in Patients With Locally Advanced Cancer of Breast and Positive Her2/Neu With Neoadjuvant Chemotherapy
BMC Cancer
Cancer Research
Oncology
Genetics
Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Followed by Docetaxel as Neoadjuvant Chemotherapy in Locally Advanced Breast Cancer (Registration Number: ChiCTR1900023052)
Scientific Reports
Multidisciplinary
The Response, Operability, and Type of Surgery Following Neoadjuvant Chemotherapy in Sudanese Patients With Locally Advanced Breast Cancer
Sudan Journal of Medical Sciences
